These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 25280865)

  • 1. Protease inhibitor monotherapy is associated with a higher level of monocyte activation, bacterial translocation and inflammation.
    Torres B; Guardo AC; Leal L; Leon A; Lucero C; Alvarez-Martinez MJ; Martinez MJ; Vila J; Martínez-Rebollar M; González-Cordón A; Gatell JM; Plana M; García F
    J Int AIDS Soc; 2014; 17(1):19246. PubMed ID: 25280865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD163/CD16 coexpression by circulating monocytes/macrophages in HIV: potential biomarkers for HIV infection and AIDS progression.
    Fischer-Smith T; Tedaldi EM; Rappaport J
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):417-21. PubMed ID: 18373432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of viremia and microbial translocation on immune activation in HIV-infected patients throughout ritonavir-boosted darunavir monotherapy.
    BenMarzouk-Hidalgo OJ; Torres-Cornejo A; Gutiérrez-Valencia A; Ruiz-Valderas R; Viciana P; López-Cortés LF
    Medicine (Baltimore); 2015 May; 94(17):e781. PubMed ID: 25929922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected women.
    Martin GE; Gouillou M; Hearps AC; Angelovich TA; Cheng AC; Lynch F; Cheng WJ; Paukovics G; Palmer CS; Novak RM; Jaworowski A; Landay AL; Crowe SM
    PLoS One; 2013; 8(1):e55279. PubMed ID: 23365694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial Translocation Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults With Suppressed Viremia.
    Younas M; Psomas C; Reynes C; Cezar R; Kundura L; Portales P; Merle C; Atoui N; Fernandez C; Le Moing V; Barbuat C; Moranne O; Sotto A; Sabatier R; Fabbro P; Vincent T; Dunyach-Remy C; Winter A; Reynes J; Lavigne JP; Corbeau P
    Front Immunol; 2019; 10():2185. PubMed ID: 31572392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection.
    Wilson EM; Singh A; Hullsiek KH; Gibson D; Henry WK; Lichtenstein K; Önen NF; Kojic E; Patel P; Brooks JT; Sereti I; Baker JV;
    J Infect Dis; 2014 Nov; 210(9):1396-406. PubMed ID: 24813472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte Based Correlates of Immune Activation and Viremia in HIV-Infected Long-Term Non-Progressors.
    Prabhu VM; Singh AK; Padwal V; Nagar V; Patil P; Patel V
    Front Immunol; 2019; 10():2849. PubMed ID: 31867010
    [No Abstract]   [Full Text] [Related]  

  • 8. HIV and cardiovascular diseases risk: exploring the interplay between T-cell activation, coagulation, monocyte subsets, and lipid subclass alterations.
    Teer E; Joseph DE; Driescher N; Nell TA; Dominick L; Midgley N; Deshpande G; Page MJ; Pretorius E; Woudberg NJ; Lecour S; Glashoff RH; Essop MF
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1146-H1157. PubMed ID: 30768357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals.
    Tippett E; Cheng WJ; Westhorpe C; Cameron PU; Brew BJ; Lewin SR; Jaworowski A; Crowe SM
    PLoS One; 2011; 6(5):e19968. PubMed ID: 21625498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.
    Abad-Fernández M; Vallejo A; Hernández-Novoa B; Díaz L; Gutiérrez C; Madrid N; Muñoz MA; Moreno S
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):149-53. PubMed ID: 24047967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viremic and Virologically Suppressed HIV Infection Increases Age-Related Changes to Monocyte Activation Equivalent to 12 and 4 Years of Aging, Respectively.
    Angelovich TA; Hearps AC; Maisa A; Martin GE; Lichtfuss GF; Cheng WJ; Palmer CS; Landay AL; Crowe SM; Jaworowski A
    J Acquir Immune Defic Syndr; 2015 May; 69(1):11-7. PubMed ID: 25647525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression and predictive value of monocyte scavenger receptor CD163 in populations with different tuberculosis infection statuses.
    Liu Q; Ou Q; Chen H; Gao Y; Liu Y; Xu Y; Ruan Q; Zhang W; Shao L
    BMC Infect Dis; 2019 Nov; 19(1):1006. PubMed ID: 31779590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.
    Wallet MA; Rodriguez CA; Yin L; Saporta S; Chinratanapisit S; Hou W; Sleasman JW; Goodenow MM
    AIDS; 2010 Jun; 24(9):1281-90. PubMed ID: 20559035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy.
    Mavigner M; Delobel P; Cazabat M; Dubois M; L'faqihi-Olive FE; Raymond S; Pasquier C; Marchou B; Massip P; Izopet J
    PLoS One; 2009 Oct; 4(10):e7658. PubMed ID: 19876401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD16-expressing monocytes correlate with arterial stiffness in HIV-infected ART-naïve men.
    Luo L; Han Y; Song X; Zhu T; Zeng Y; Li T
    HIV Clin Trials; 2018 Apr; 19(2):39-45. PubMed ID: 29770747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers of T Cell Exhaustion and Senescence and Their Relationship to Plasma TGF-β Levels in Treated HIV+ Immune Non-responders.
    Shive CL; Freeman ML; Younes SA; Kowal CM; Canaday DH; Rodriguez B; Lederman MM; Anthony DD
    Front Immunol; 2021; 12():638010. PubMed ID: 33868264
    [No Abstract]   [Full Text] [Related]  

  • 17. IL-10 induces activated phenotypes of monocytes observed in virally-suppressed HIV-1-infected individuals.
    Takahashi N; Eltalkhawy YM; Nasu K; Abdelnaser RA; Monde K; Habash SA; Nasser H; Hiyoshi M; Ishimoto T; Suzu S
    Biochem Biophys Res Commun; 2024 Oct; 729():150342. PubMed ID: 38981402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: a changing paradigm for routine HIV laboratory monitoring?
    Castley A; Berry C; French M; Fernandez S; Krueger R; Nolan D
    PLoS One; 2014; 9(12):e115226. PubMed ID: 25544986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocyte activation, HIV, and cognitive performance in East Africa.
    Muñoz-Nevárez LA; Imp BM; Eller MA; Kiweewa F; Maswai J; Polyak C; Olwenyi OA; Allen IE; Rono E; Milanini B; Kibuuka H; Ake JA; Eller LA; Valcour VG
    J Neurovirol; 2020 Feb; 26(1):52-59. PubMed ID: 31468471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The independent effect of drug resistance on T cell activation in HIV infection.
    Hunt PW; Deeks SG; Bangsberg DR; Moss A; Sinclair E; Liegler T; Bates M; Tsao G; Lampiris H; Hoh R; Martin JN
    AIDS; 2006 Mar; 20(5):691-9. PubMed ID: 16514299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.